M‑1121

N/A

Report date: 2022/06/29 15:08:31
NME

Base Information

Drug NameM‑1121
Drug Alias NameM‑1121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMenin/Histone-lysine N-methyltransferase 2A MLL inhibitors
TargetsHistone-lysine N-methyltransferase 2AMenin
Therapy Area/IndicationsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Michigan
Inactive CompaniesN/A
Active IndicationsLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A